CTKB VS HCSG Stock Comparison

PerformanceTechnicalsEarningsProfitVolatilityAnalyst Price TargetsSentimentDividend
PerformanceTechnicalsEarningsProfitVolatilityAnalyst Price TargetsSentimentDividend

Performance

CTKB
10/100

CTKB returned -67.30% in the last 12 months. Based on SPY's performance of 9.73%, its performance is below average giving it a score of 10 of 100.

HCSG
10/100

HCSG returned -30.39% in the last 12 months. Based on SPY's performance of -12.93%, its performance is below average giving it a score of 10 of 100.

Technicals

CTKB
46/100

CTKB receives a 46 of 100 based on 14 indicators. 6 are bullish, 7 are bearish.

HCSG
50/100

HCSG receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

Earnings

CTKB
43/100

CTKB has missed earnings 2 times in the last 20 quarters.

HCSG
10/100

HCSG has missed earnings 7 times in the last 20 quarters.

Profit

CTKB
38/100

Out of the last 15 quarters, CTKB has had 8 profitable quarters and has increased their profits year over year on 2 of them.

HCSG
72/100

Out of the last 20 quarters, HCSG has had 19 profitable quarters and has increased their profits year over year on 8 of them.

Volatility

CTKB
49/100

CTKB has had a lower than average amount of volatility over the last 12 months giving it a score of 49 of 100.

HCSG
55/100

HCSG has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.

Analyst Price Targets

CTKB

"Analyst Price Targets" not found for CTKB

HCSG
75/100

7 analysts offer 12-month price targets for HCSG. Together, they have an average target of 19, the most optimistic target put HCSG at 20 within 12-months and the most pessimistic has HCSG at 18.

Sentiment

CTKB

"Sentiment" not found for CTKB

HCSG
71/100

HCSG had a bullish sentiment score of 71.08% across Twitter and StockTwits over the last 12 months. It had an average of 2.00 posts, 0.50 comments, and 0.00 likes per day.

Dividend

CTKB

"Dividend" not found for CTKB

HCSG
92/100

HCSG's most recent dividend was $0.20 per share, based on a share price of $10.01. It was a payout ratio of 45.81% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Cytek Biosciences, Inc. Common Stock Summary

Nasdaq / CTKB
Healthcare
Medical - Devices
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Healthcare Services Group Summary

Nasdaq / HCSG
Healthcare
Medical - Care Facilities
Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the client's facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client's facility. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. As of December 31, 2021, the company provided its services to approximately 3,000 facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.